UK Markets open in 6 hrs 27 mins

Fresenius Medical Care AG & Co. KGaA (FME.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
56.30+0.48 (+0.86%)
At close: 05:35PM CEST
Full screen
Previous close55.82
Open56.00
Bid56.34 x 38700
Ask56.38 x 105300
Day's range55.84 - 56.76
52-week range50.98 - 71.14
Volume429,489
Avg. volume573,770
Market cap16.496B
Beta (5Y monthly)0.98
PE ratio (TTM)17.97
EPS (TTM)3.13
Earnings date21 Feb 2022 - 25 Feb 2022
Forward dividend & yield1.35 (2.39%)
Ex-dividend date13 May 2022
1y target est63.86
  • Business Wire

    Fresenius Medical Care Celebrates Diversity and Unity of a Global Nurse Workforce

    HONG KONG, May 12, 2022--Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today announced its global ‘United in Care’ campaign that celebrates the diversity, unity and positive impact of its nurses and clinical teams across Asia Pacific, Europe, the Middle East and Africa, North America and Latin America.

  • Zacks

    Fresenius Medical (FMS) Q1 Earnings & Revenues Top Estimates

    Fresenius Medical's (FMS) first-quarter earnings benefit from strong performance across all the geographic regions and segments.

  • Reuters

    Fresenius warns of bigger Ukraine war impact after Q1 profit beat

    German healthcare group Fresenius's first-quarter profit exceeded market expectations on Wednesday, driven by growth in its generic infusion drugs unit in emerging markets. However, the group warned cost inflation and supply chain disruptions were likely to increase this year, fuelled by Russia's invasion of Ukraine. Fresenius's businesses include the Helios hospital chain, drugmaker Kabi, medical services firm Vamed and dialysis specialist Fresenius Medical Care (FMC).